Drug‐drug interactions with candidate medications used for COVID‐19 treatment: An overview

• Autori principali: Haleh Rezaee (Autore), Fariba Pourkarim (Autore), Samira Pourtaghi‐Anvarian (Autore), Taher Entezari‐Maleki (Autore), Touraj Asvadi‐Kermani (Autore), Masoud Nouri‐Vaskeh (Autore)
• Natura: Libro
• Pubblicazione: Wiley, 2021-02-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Abstract Drug‐drug interaction (DDI) is a common clinical problem that has occurred as a result of the concomitant use of multiple drugs. DDI may occur in patients under treatment with medications used for coronavirus disease 2019 (COVID‐19; i.e., chloroquine, lopinavir/ritonavir, ribavirin, tociliz...